Get started
Author

Hironori Betsunoh

Observed names: Betsunoh, Hironori, H. Betsunoh, HIRONORI BETSUNOH, Hironori Betsuno
ORCID: 0000-0002-7873-3568
Observed ORCID: 0000-0002-7873-3568
OpenAlex ID: A5062016951
Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
2007 · Hironori Betsunoh, Shoichiro Mukai, et al. · Cancer Science · 86
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
2013 · Hironori Betsunoh, Takehiko Fukuda, et al. · BMC Cancer · 82
PDF
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells
2014 · Hideyuki Abe, Takao Kamai, et al. · BMC Cancer · 51
PDF
Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations
2004 · RYOICHI HAMASUNA, HIRONORI BETSUNOH, et al. · International Journal of Urology · 51
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
2015 · Tomoya Mizuno, Takao Kamai, et al. · BMC Cancer · 34
PDF
Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
2014 · Akinori Masuda, Kyoko Arai, et al. · BioMed Research International · 24
PDF
Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold
2019 · Minoru Kobayashi, Tomoya Mizuno, et al. · International Journal of Clinical Oncology · 19
Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer
2018 · Takao Kamai, Yuumi Tokura, et al. · Open Heart · 19
PDF
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
2020 · Akinori Nukui, Takao Kamai, et al. · Cancer Immunology Immunotherapy · 17
PDF
Metronomic Oral Cyclophosphamide Chemotherapy Possibly Contributes to Stabilization of Disease in Patients With Metastatic Castration-Resistant Prostate Cancer: A Prospective Analysis of Consecutive Cases
2014 · Masahiro Yashi, Daisaku Nishihara, et al. · Clinical Genitourinary Cancer · 15
Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis
2018 · Hideo Yuki, Takao Kamai, et al. · Oncotarget · 13
PDF
Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy
2014 · Masahiro Yashi, Tomoya Mizuno, et al. · BMC Urology · 13
PDF
Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy
2017 · Masahiro Yashi, Akinori Nukui, et al. · BMC Urology · 11
PDF
Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma
2025 · Toshiki Kijima, Atsuko Takada‐Owada, et al. · BJUI Compass · 9
5‑Fluorouracil‑based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase
2019 · Takahiro Narimatsu, Tsunehito Kambara, et al. · Oncology Letters · 9
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report
2014 · Takao Kamai, Hideo Yuki, et al. · OncoTargets and Therapy · 9
PDF
Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients
2023 · Kohei Takei, Toshiki Kijima, et al. · Cancers · 7
PDF
The Predictive Value of Glycated Hemoglobin and Albumin for the Clinical Course Following Hospitalization of Patients with Febrile Urinary Tract Infection
2018 · Minoru Kobayashi, Toshitaka Uematsu, et al. · Infection and Chemotherapy · 7
PDF
Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study
2022 · Koji Ichihara, Satoshi Takahashi, et al. · Journal of Infection and Chemotherapy · 6
Clinical Significance of18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma
2021 · HIRONORI BETSUNOH, SETSU SAKAMOTO, et al. · Anticancer Research · 6
PDF
Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study
2025 · Toshiki Kijima, Atsuko Takada‐Owada, et al. · International Journal of Urology · 4
PDF
Extravasation of Urine Associated with Bilateral Complete Ureteral Duplication, Vesicoureteral Reflux and Benign Prostatic Hyperplasia
2017 · Issei Suzuki, Kanya Kaga, et al. · Urology Case Reports · 4
PDF
Transperitoneal laparoscopic umbilical resection of urachal remnants: a feasible surgical method
2023 · Hideo Yuki, Naoya Ohkubo, et al. · BMC Urology · 3
PDF
ΔBSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents
2025 · Hidetoshi Kokubun, Toshiki Kijima, et al. · Annals of Nuclear Medicine · 2
PDF
Utility of whole‐body diffusion‐weighted magnetic resonance imaging in the management of treatment‐related neuroendocrine prostate cancer
2020 · Ryo Kurashina, Toshiki Kijima, et al. · IJU Case Reports · 2
PDF
Works count: 43
Citation count: 505
H-index: 12
I10-index: 13
Year
Topic
Type